Search Results - "Laman, M.S."

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy by Rijkmans, E.C, Nout, R.A, Rutten, I.H.H.M, Ketelaars, M, Neelis, K.J, Laman, M.S, Coen, V.L.M.A, Gaarenstroom, K.N, Kroep, J.R, Creutzberg, C.L

“…Abstract Objective Since the Group Européen de Curiethérapie and the European Society for Radiotherapy and Oncology (GEC–ESTRO) published recommendations for…”
Get full text

OC-0363: Ruthenium-106 brachytherapy for iris and choroidal body melanomas by Peters, F.P., Marinkovic, M., Horeweg, N., Laman, M.S., Bleeker, J.C., Ketelaars, M., Luyten, G.P.M., Creutzberg, C.L.

Get full text

OC-0280: Benefit of repeat CT in high-dose rate brachytherapy as radical treatment for rectal cancer by Van den Ende, R.P.J., Rijkmans, E.C., Kerkhof, E.M., Nout, R.A., Ketelaars, M., Laman, M.S., Marijnen, C.A.M., Van der Heide, U.A.

Get full text

PO-0808: Efficacy and toxicity of chemoradiation with brachytherapy for locally advanced cervical cancer by Horeweg, N., Creutzberg, C.L., Rijkmans, E.C., Laman, M.S., Velema, L.A., Coen, V.L.M.A., Stam, T.C., Kerkhof, E.M., Kroep, J.R., De Kroon, C.D., Nout, R.A.

Get full text

OC-0280: Proctitis after brachytherapy for rectal cancer: clinical and dosimetric factors - The HERBERT study by Rijkmans, E.C., Nout, R.A., Kerkhof, E.M., Cats, A., Van Triest, B., Inderson, A., Van den Ende, R.P.J., Laman, M.S., Ketelaars, M., Marijnen, C.A.M.

Get full text

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer by Wortman, B.G., Astreinidou, E., Laman, M.S., van der Steen-Banasik, E.M., Lutgens, L.C.H.W., Westerveld, H., Koppe, F., Slot, A., van den Berg, H.A., Nowee, M.E., Bijmolt, S., Stam, T.C., Zwanenburg, A.G., Mens, J.W.M., Jürgenliemk-Schulz, I.M., Snyers, A., Gillham, C.M., Weidner, N., Kommoss, S., Vandecasteele, K., Tomancova, V., Creutzberg, C.L., Nout, R.A.

“…•Quality assurance is essential for uniform treatment in multi-institutional radiotherapy trials.•At dummy run, 71.4% of the brachytherapy plans needed…”
Get full text

Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study by Rijkmans, E.C., van Triest, B., Nout, R.A., Kerkhof, E.M., Buijsen, J., Rozema, T., Franssen, J.H., Velema, L.A., Laman, M.S., Cats, A., Marijnen, C.A.M.

“…The HERBERT study evaluated a high-dose-rate endorectal brachytherapy boost (HDREBT) after EBRT in medically inoperable/elderly patients with rectal cancer…”
Get full text

PV-0328: Factors associated with complete response after brachytherapy for rectal cancer; the HERBERT study by Rijkmans, E.C., Nout, R.A., Kerkhof, E.M., Cats, A., Van Triest, B., Inderson, A., Van den Ende, R.P.J., Laman, M.S., Ketelaars, M., Marijnen, C.A.M.

Get full text